These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 28207639

  • 1. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN.
    Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MELD exceptions for portopulmonary hypertension: current policy and future implementation.
    Goldberg DS, Batra S, Sahay S, Kawut SM, Fallon MB.
    Am J Transplant; 2014 Sep; 14(9):2081-7. PubMed ID: 24984921
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sex Differences in Portopulmonary Hypertension.
    DuBrock HM, Cartin-Ceba R, Channick RN, Kawut SM, Krowka MJ.
    Chest; 2021 Jan; 159(1):328-336. PubMed ID: 32798521
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension.
    Cartin-Ceba R, Burger C, Swanson K, Vargas H, Aqel B, Keaveny AP, Heimbach J, Taner T, Nyberg S, Rosen C, Cajigas H, DuBrock H, Krowka MJ.
    Transplantation; 2021 Oct 01; 105(10):2283-2290. PubMed ID: 33065725
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension.
    Jose A, Shah SA, Anwar N, Jones CR, Sherman KE, Elwing JM.
    Liver Transpl; 2021 Dec 01; 27(12):1811-1823. PubMed ID: 33964116
    [Abstract] [Full Text] [Related]

  • 15. Portopulmonary hypertension: an update.
    Safdar Z, Bartolome S, Sussman N.
    Liver Transpl; 2012 Aug 01; 18(8):881-91. PubMed ID: 22674534
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.
    Goldberg D, French B, Abt P, Feng S, Cameron AM.
    Liver Transpl; 2012 Apr 01; 18(4):434-43. PubMed ID: 22271656
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Nobel YR, Goldberg DS.
    Transplantation; 2015 Nov 01; 99(11):2341-6. PubMed ID: 25989503
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.